Full portfolio of SARS-CoV-2 Antibody ELISAs to suit your needs for stage of immune response, sensitivity needs, and price point.

Posted: January 12, 2021

QUANTITATIVE SARS-CoV-2 ELISAs for detection of IgG antibodies

The quality you trust from DiaPharma

Full portfolio of SARS-CoV-2 Antibody ELISAs to suit your needs for stage of immune response, sensitivity needs, and price point.

• Ideal for COVID-19 research, epidemiological studies, vaccine development, long-term efficacy or sustainability of immune response
• Open-system, standard ELISAs that require no special readers and can be automated for higher throughput

QUANTITATIVE SARS-CoV-2 ELISAs for detection of IgG antibodies

 

QUANTITATIVE SARS-CoV-2 ELISAs for detection of IgG antibodies

QUANTITATIVE SARS-CoV-2 ELISAs for detection of IgG antibodies

Brought to you by our partner, Technoclone. Kits manufactured in Austria in collaboration with Florian Krammer, PhD (Icahn School of Medicine at Mount Sinai, New York)

*Research use only in the U.S. and Canada

TECHNOZYM anti SARS-CoV-2 NP IgG ELISA kit

  • Reacts sensitively in the early stages of the immune response
  • Includes 96 test wells + calibrator and control material
  • Cut-off: 5 U/mL
  • Negative Agreement: 99.8%
Positive Agreement (days post symptom onset):

<5 days 14.7%
5-10 days 45.7%
11-15 days 76.5%
>15 days 100%

 

TECHNOZYM anti SARS-CoV-2 RBD IgG test kit

  • Reacts sensitively in the later stages of the immune response
  • Includes 96 test wells + calibrator and control material
  • Cut-off: 5 U/mL
  • Negative Agreement: 99.3%
Positive Agreement (days post symptom onset):

<5 days 5.9%
5-10 days 34.3%
11-15 days 64.7%
>15 days 100%

SARS-CoV-2 ELISAs

Product Part Number RUO or Clinical Antibody Target Antigenic Target Top Sensitivity (time-dependent) Top Specificity (time-dependent) Features
RAPIT COVID-19 lgM/ lgG Test Kit RUOCL0100NS0 RUO one line for IgM and IgG N and S in same test 91.10% 95.40% Rapid, Whole Blood or Serum
COVID19N-REAAD™ Anti-SARS-CoV-2 Nucleocapsid lgG ELISA RUOCE0100NP1 RUO IgG N protein 98.20% 100%
COVID19-REAAD™ Anti-SARS-CoV-2 lgG ELISA RUOCE0200NS2 RUO IgG Both N + S1RBD Not Reported Not Reported
SARS-CoV-2 IgG ELISA Test Kit GSD01-1028 EUA Submitted IgG N protein 100% 100% FDA EUA Submitted
TECHNOZYM anti SARSCoV-2 NP IgG ELISA 5600200 RUO IgG N protein 100%
>15d
99.80% Quantitative, using a standard curve
TECHNOZYM anti SARSCoV-2 RBD IgG ELISA 5600100 RUO IgG RBD 100%
>15d
99.30% Quantitative, using a standard curve
Generic Assays
SARS-CoV-2 IgG+
3940 RUO IgG Separate S1, S2, N > 98% > 98% More samples per plate than with Calibrators
Generic Assays
SARS-CoV-2 IgG
3920 RUO IgG S1 and N > 98% > 98% More samples per plate than with Calibrators
Generic Assays
SARS-CoV-2 IgM
3930 RUO IgM S1 and N > 98% > 98% More samples per plate than with
Calibrators
Generic Assays SARS-CoV-2 NP IgG ELISA Kit 41A222R RUO IgG N protein 93.30% 93.89% Use with plasma or serum
Generic Assays SARS-CoV-2 S1RBD IgG ELISA 41A223R RUO IgG S1 RBD Not Reported Not Reported Use with plasma or serum
SARS-CoV-2 NP IgM ELISA Kit 41A224R RUO IgM N protein 88.64% 96.31% Use with plasma or serum
SARS-CoV-2 NP Ab ELISA Kit 41A225R RUO Total Antibodies N protein 93.30% 95% Use with plasma or serum High-sensitive
SARS-CoV-2 S1RBD IgG ELISA Kit 41A240R RUO IgG S1 >96% >96% Use with plasma or serum
SARS-CoV-2 S1 IgA ELISA Kit 41A247R RUO IgA S1 >96% >95% Use with plasma or serum
SARS-CoV-2 NP IgA ELISA Kit 41A248R RUO IgA N protein N/A N/A Use with plasma or serum

 

Questions about any product in our lineup?
We’re just a click or phone call away.

800.526. 5224 | info@diapharma.com | diapharma.com

 

*Research use only in the U.S. and Canada

QUANTITATIVE SARS-CoV-2 ELISAs for detection of IgG antibodies

ML-00-00753Rev01